Comparison of morning basal + 1 bolus insulin therapy (insulin glulisine + insulin glargine 300 U/mL vs insulin lispro + insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study

Samankaltaisia teoksia

• Comparison of the efficacy and safety of insulin degludec/aspart (twice‐daily injections), insulin glargine 300 U/mL, and insulin glulisine (basal–bolus therapy)
  Tekijä: Kawaguchi, Yuji, et al.
  Julkaistu: (2019)
• Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml
  Tekijä: Steinstraesser, A, et al.
  Julkaistu: (2014)
• A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
  Tekijä: Candido, Riccardo, et al.
  Julkaistu: (2018)
• Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice
  Tekijä: Hidvégi, Tibor, et al.
  Julkaistu: (2020)
• Continuous Glucose Monitoring During Basal–Bolus Therapy Using Insulin Glargine 300 U mL(−1) and Glargine 100 U mL(−1) in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study
  Tekijä: Jinnouchi, Hideaki, et al.
  Julkaistu: (2015)